BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nerella SG, Singh P, Arifuddin M, Supuran CT. Anticancer carbonic anhydrase inhibitors: a patent and literature update 2018-2022. Expert Opin Ther Pat 2022. [PMID: 35616541 DOI: 10.1080/13543776.2022.2083502] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Denner TC, Heise N, Zacharias J, Kraft O, Hoenke S, Csuk R. Small Structural Differences Govern the Carbonic Anhydrase II Inhibition Activity of Cytotoxic Triterpene Acetazolamide Conjugates. Molecules 2023;28:1009. [DOI: 10.3390/molecules28031009] [Reference Citation Analysis]
2 Supuran CT. Latest advances in specific inhibition of tumor-associated carbonic anhydrases. Future Med Chem 2023. [PMID: 36636980 DOI: 10.4155/fmc-2022-0249] [Reference Citation Analysis]
3 Mahapatra M, Mekap SK, Mal S, Sahoo J, Sahoo SK, Paidesetty SK. Coumaryl-sulfonamide moiety: Unraveling their synthetic strategy and specificity toward hCA IX/XII, facilitating anticancer drug development. Arch Pharm (Weinheim) 2023;:e2200508. [PMID: 36587981 DOI: 10.1002/ardp.202200508] [Reference Citation Analysis]
4 Zareei S, Mohammadi-khanaposhtani M, Adib M, Mahdavi M, Taslimi P. Sulfonamide-phosphonate hybrids as new carbonic anhydrase inhibitors: In vitro enzymatic inhibition, molecular modeling, and ADMET prediction. Journal of Molecular Structure 2023;1271:134114. [DOI: 10.1016/j.molstruc.2022.134114] [Reference Citation Analysis]
5 Abo-Ashour MF, Almahli H, Bonardia A, Khalil A, Al-Warhi T, Al-Rashood ST, Abdel-Aziz HA, Nocentini A, Supuran CT, Eldehna WM. Enaminone-based carboxylic acids as novel non-classical carbonic anhydrases inhibitors: design, synthesis and in vitro biological assessment. J Enzyme Inhib Med Chem 2022;37:2256-64. [PMID: 36000171 DOI: 10.1080/14756366.2022.2114079] [Reference Citation Analysis]
6 Al-Warhi T, Elbadawi MM, Bonardi A, Nocentini A, Al-Karmalawy AA, Aljaeed N, Alotaibi OJ, Abdel-Aziz HA, Supuran CT, Eldehna WM. Design and synthesis of benzothiazole-based SLC-0111 analogues as new inhibitors for the cancer-associated carbonic anhydrase isoforms IX and XII. J Enzyme Inhib Med Chem 2022;37:2635-43. [PMID: 36146927 DOI: 10.1080/14756366.2022.2124409] [Reference Citation Analysis]
7 Abdel-Mohsen HT, Omar MA, Petreni A, Supuran CT. Novel 2-substituted thioquinazoline-benzenesulfonamide derivatives as carbonic anhydrase inhibitors with potential anticancer activity. Arch Pharm (Weinheim) 2022;:e2200180. [PMID: 36056903 DOI: 10.1002/ardp.202200180] [Reference Citation Analysis]
8 Rai D, Khatua S, Taraphder S. Structure and Dynamics of the Isozymes II and IX of Human Carbonic Anhydrase. ACS Omega. [DOI: 10.1021/acsomega.2c03356] [Reference Citation Analysis]
9 Giovannuzzi S, Capasso C, Nocentini A, Supuran CT. Continued Structural Exploration of Sulfocoumarin as Selective Inhibitor of Tumor-Associated Human Carbonic Anhydrases IX and XII. Molecules 2022;27:4076. [DOI: 10.3390/molecules27134076] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Brandes B, Orlamünde TE, Hoenke S, Denner TC, Al-harrasi A, Csuk R. Selective and low-cost triterpene urea and amide derivatives of high cytotoxicity and selectivity. Results in Chemistry 2022;4:100610. [DOI: 10.1016/j.rechem.2022.100610] [Reference Citation Analysis]